-
Innovation Ranking
Innovation Ranking – Infinity Pharmaceuticals Inc
Infinity Pharmaceuticals Inc (Infinity Pharmaceuticals) is a biopharmaceutical company which discovers and develops small molecule therapeutics for the treatment of cancer. The company’s pipeline candidate: IPI-549 selectively inhibits PI3K-gamma to reprogram tumor-associated macrophages and transforms immuno-oncology approach. The company is evaluating IPI-549 as a monotherapy and in a combination therapy in various clinical trials for the treatment of various indications such advanced solid tumors, non-small cell lung cancer (NSCLC), melanoma, squamous cell carcinoma of the head and neck (SCCHN), triple...
-
Product Insights
Ultrasound Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ultrasound Systems Pipeline Market Report Overview Ultrasound Systems are devices that make use of sound waves of high frequency to produce images of structures inside the body. Most of the devices use Sonar principles and are placed outside while in a few cases, they are even placed inside of the body. 2D Ultrasound Systems, 3D Ultrasound Systems, Real-Time 3D Ultrasound Systems, and Hand Held Ultrasound (HHU) Systems are tracked under this category. The Ultrasound Systems pipeline market research report provides...
-
Sector Analysis
Middle East and Africa (MEA) Hydrogen Market Size and Analysis by Application Areas, Upcoming Projects, Policies and Key Players to 2030
Middle East and Africa (MEA) Hydrogen Market Report Overview The active hydrogen capacity in the MEA stood at 0.21 mtpa as of February 2024. The MEA region is emerging as a key player within the emerging hydrogen market. The region has several large-scale low-carbon hydrogen projects in the pipeline that will boost its positioning within the global hydrogen market. Many African countries will be key contributors to the MEA’s emerging hydrogen market including Egypt, Mauritania, Morocco, and South Africa as...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Eganelisib in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Eganelisib in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Eganelisib in Non-Small Cell Lung Cancer Drug Details: Eganelisib is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Eganelisib in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Eganelisib in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Eganelisib in Triple-Negative Breast Cancer (TNBC) Drug Details: Eganelisib is...
-
Thematic Analysis
Travel and Tourism M&A Deals 2023 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in 2023 in the Travel & Tourism Sector
-
Analyst Opinions
Africa Energy Transition Market Trends and Analysis by Sectors and Companies Driving Development
Africa Energy Transition Market Report Overview Africa is set to experience significant social, economic, and environmental changes that will heavily influence the region’s energy demand in the coming years. The power market in Africa still heavily relies on a combination of thermal power and large-scale hydropower projects to meet its power demand. However, the region’s energy transition is gaining pace as countries increasingly capitalize on the falling cost of producing renewable energy and the region’s rich renewable resources, which is...
-
Product Insights
NewGallbladder Cancer – Drugs In Development, 2024
Empower your strategies with our Gallbladder Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Gallbladder cancer symptoms include abdominal pain, nausea and/or vomiting, jaundice, loss of appetite, fever, itchy skin, dark urine, and weight loss. Risk factors include overweight, age, family history, gallstones, gender, and choledochal cysts. Treatment includes surgery, chemotherapy, and radiation therapy. The Gallbladder Cancer drugs in development market research report provide comprehensive information on the therapeutics under development for Gallbladder Cancer, complete with...